BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: He J, Jiang YL, Wang Y, Tian XJ, Sun SR. Micro-vesicles from mesenchymal stem cells over-expressing miR-34a inhibit transforming growth factor-β1-induced epithelial-mesenchymal transition in renal tubular epithelial cells in vitro. Chin Med J (Engl) 2020;133:800-7. [PMID: 32149762 DOI: 10.1097/CM9.0000000000000720] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Corrêa RR, Juncosa EM, Masereeuw R, Lindoso RS. Extracellular Vesicles as a Therapeutic Tool for Kidney Disease: Current Advances and Perspectives. Int J Mol Sci 2021;22:5787. [PMID: 34071399 DOI: 10.3390/ijms22115787] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Chen S, Sun F, Qian H, Xu W, Jiang J, Bruno S. Preconditioning and Engineering Strategies for Improving the Efficacy of Mesenchymal Stem Cell-Derived Exosomes in Cell-Free Therapy. Stem Cells International 2022;2022:1-18. [DOI: 10.1155/2022/1779346] [Reference Citation Analysis]
3 Brigstock DR. Extracellular Vesicles in Organ Fibrosis: Mechanisms, Therapies, and Diagnostics. Cells 2021;10:1596. [PMID: 34202136 DOI: 10.3390/cells10071596] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
4 Yan C, Yu J. Noncoding RNA in Extracellular Vesicles Regulate Differentiation of Mesenchymal Stem Cells. Front Dent Med 2022;2:806001. [DOI: 10.3389/fdmed.2021.806001] [Reference Citation Analysis]
5 Lin S, Lin W, Liao C, Zhou T. Nephroprotective Effect of Mesenchymal Stem Cell-Based Therapy of Kidney Disease Induced by Toxicants. Stem Cells Int 2020;2020:8819757. [PMID: 33424979 DOI: 10.1155/2020/8819757] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]